CSI: Ancient Alexandria

A reexamination of the facts surrounding the death of Cleopatra VII reveals that the Egyptian queen was murdered—and not by an asp.

Written byPat Brown
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PROMETHEUS BOOKS, FEBRUARY 2013Three circumstances attend any death: the cause (specific disease or injury), the mechanism (type of physiological damage), and the manner (natural, accidental, suicide, or murder). Sometimes all three of these are obvious. Other times, we can determine none of them. Today, some 2,000 years after the famed Egyptian queen Cleopatra met her demise in Alexandria, there is no absolute proof of how or why she died. The circumstances surrounding her death are quite murky.

The closest thing we have to a firsthand account is the oft-repeated tale told by Greek historian Plutarch, who was not even alive during Cleopatra’s reign. So his story is just that—a story. He claims that while under guard in her tomb, tending to the body of Antony following the surrender of Egyptian forces to the Roman general Octavian, Cleopatra chose to end her life rather than be taken back to Rome and shown off as a spoil of war. Plutarch says she smuggled a snake into the tomb, where she and her two handmaidens used the serpent’s venomous bite to commit suicide. Yet there were no outward signs that venom had caused their deaths.

I systematically review the available evidence, and debunk this historical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies